跳至主要内容
临床试验/CTRI/2011/12/002242
CTRI/2011/12/002242进行中(未招募)1 期

A Companion Glucose-6-Phosphate Dehydrogenase (G6PD)enzyme assay validation protocol to the study TAF112582

GlaxoSmithKline Pharmaceuticals Ltd0 个研究点目标入组 324 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
324

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. The subject is between 18 and 45 years of age, inclusive,
  • 2. The subject is male,
  • 3. The subject has a Hgb concentration ≥12g/dL
  • 4. The subject has a reticulocyte count ≤ 2.5%
  • 5. A signed and dated informed consent is obtained from the subject or the subject?s
  • legal representative prior to screening.

排除标准

  • History of haemoglobinopathy (e.g. sickle cell disease, hereditary spherocytosis,
  • thalassaemias, haemoglobin M/E, etc.); past or current history of
  • methaemoglobinaemia or methaemoglobin percentage above 3%
  • 2. Past medical history of G6PD deficiency
  • 3. Any other co-morbidity or treatment that, in the opinion of the investigator, might
  • influence haematopoiesis
  • 4. Any person that may have donated blood in the last 56 days

研究者

相似试验